Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 14, 2007

CytoDyn Selects Waisman Facility to Manufacture DNA-based Preflu Vaccine

  • CytoDyn chose the Waisman Clinical BioManufacturing Facility at the University of Wisconsin at Madison to manufacture its DNA-based preflu vaccine. The company says the product provides an alternative approach to immunization that could make flu vaccines for the seasonal flu and bird flu more effective.

    The vaccine uses DNA technology to implant a false memory of previous exposure to the flu virus, including the inactivated virus contained in standard vaccines.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »